Calder Biosciences
Creating Next-Generation Vaccines to Protect Against Infection
Based based in New York, US, Calder Biosciences works in therapeutics, founded in 2018.
Profile
Calder is a nano-scale, molecular engineering company that is applying its platform technology to engineer and develop novel vaccines that allow billions of people to stay healthy. We’re developing safe, effective, durable, and tolerable vaccines that protect against RSV, all strains of seasonal and pandemic influenza, and other harmful, viral infections.
Within the therapeutics space, the company focuses on its core offering rather than a broad product line.
The business is associated with New York, US.
Its current recorded stage is SOSV portfolio company.
Recorded headcount: 2-10 employees.
Public records show total funding of about $625.
| Sector | Therapeutics |
|---|---|
| Headquarters | New York, US |
| Country | United States |
| Founded | 2018 |
| Employees | 2-10 |
| Stage | SOSV portfolio company |
| Total funding | $625 |
Website: www.calderbiosciences.com
Create a free account